(thirdQuint)Randomized, Controlled Study to Compare Straumann VivOss to Geistlich Bio-Oss in Sinus Floor Augmentation.

.

 This is a prospective, randomized, controlled study.

 The total study duration for each patient should be 9-14 months (from screening to last visit).

 Enrolled subjects are randomized to one of the following groups: 1.

 Sinus floor elevation with Straumann(R) VivOss cent 2.

 Sinus floor elevation with Geistlich Bio-Oss(R) In total 6 visits per patient are scheduled in this study.

 The histological evaluation of the ratio of newly formed bone to residual bone graft, survival and success rate of study implants and adverse events (AEs) will be assessed.

 The study devices Straumann(R) VivOss cent and Geistlich Bio-Oss are CE-(Conformite Europeenne, meaning European Conformity) marked products.

 Two centers, one in Germany and one in Switzerland will participate.

.

 Randomized, Controlled Study to Compare Straumann VivOss to Geistlich Bio-Oss in Sinus Floor Augmentation.

@highlight

A randomized controlled clinical trial to investigate the capability of Straumann(R) VivOss cent compared to Geistlich Bio-Oss in sinus floor augmentation to demonstrate superiority of Straumann(R) VivOss cent compared to Geistlich Bio-Oss in regards to the ratio of newly formed bone to residual bone substitute.

